Road to AgSuccess?

Rosetta Green, an Israeli biotech company focused on uncovering genes that can be used to improve agricultural and biofuel crops, has been bought by Monsanto fro $35 million, reports Bioentrepreneur's Trade Secrets blog. Rosetta Green was a spinoff from Rosetta Genomics.

This, writes Bernard Dichek at Trade Secrets, could be the beginning of a trend.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in PNAS

Still Concerns

This Week in PLOS

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.